Roche Reports 7% 1H25 Sales Growth, Key Drugs Perform Well

• click to rate

  Posted by Two Blokes Jul 24 - Filed in Stock - 8 views
  
  RHHBY posts solid first-half 2025 growth on strong drug demand, but pipeline setbacks and biosimilar hits remain headwinds.